Willow Trace presented a unique opportunity for an incoming investor to obtain a skilled nursing facility with limited local competition and a long history of strong cashflow. While the operator has a large regional presence, the facility was deemed a geographical outlier. Ownership recognized the value in running a process to strategically divest of Willow Trace.
Blueprint’s expertise in the Southeast and depth in the market helped to achieve maximum value by adding the asset into a larger portfolio simultaneously being sold by Blueprint. The in-place cashflow from the facility increased the attractiveness of the larger portfolio and commanded a premium for Willow Trace. Through strong in-state relationships, the Blueprint team was able to help the buyer successfully navigate the nuances of licensure and closing in a new state.
The transaction was handled by Brooks Blackmon and Trent Gherardini.